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Most of the mutations causing deficiency of the pyruvate dehydrogenase (PDH) complex are in the 
X-linked E ^  gene. We have developed a rapid screening method for the detection of mutations in this 
gene using reverse transcription of total RNA, polymerase chain reaction amplification of the whole 
coding region of the gene and single-strand conformation polymorphism (SSCP) analysis. With this 
method, we studied eight patients with a PDH complex deficiency, using cultured fibroblasts. In all 
patients, aberrant SSCP patterns were found and, after sequencing of the corresponding fragments, we 
were able to identify six new mutations and two mutations already described previously. The mutations 
are point mutations leading to amino acid substitutions (5) and direct repeat insertions (3). The 
presence of the mutations was confirmed in genomic fibroblast DNA* The 4 female patients were 
shown to carry both a normal and a mutated Exa  gene. © 1996 Wiley^Liss, Inc,
k e y  w o r d s :  Pyruvate dehydrogenase Eta, RT-PCR, SSCP, Mutation analysis
INTRODUCTION
The pyruvate dehydrogenase (PDH) complex 
catalyzes the irreversible conversion of pyruvate to 
acetyl-CoA. The complex is localized in the mi­
tochondria and connects glycolysis with the citric 
acid cycle and oxidative phosphorylation. It con­
sists of multiple copies of three catalytic enzymes 
Elf E2, and E3, a protein with an unknown func- 
tion (protein X) and two enzymes regulating the 
activation/inactivation of the Ex enzyme.
Human PDH complex deficiency is one of the 
most prominent causes of primary congenital lactic
acidosis (Robinson, 1989, 1993). Studies at both 
the molecular and protein levels have demon­
strated that in most patients the reduction in ac­
tivity of the complex is due to defects in the Ex
component (Robinson, 1989; Dahl et al., 1992a).
The Ei enzyme is a heterotetramer of 2a and 2(3- 
subunits, but so far only mutations in the E{a  gene
have been found. This gene is approximately 17 
kilobase (kb) long, contains 11 exons, and is lo- 
calized on the X-chromosome in band Xp22.1 
(Koike et al., 1990; Maragos et a l., 1989; Brown et 
alM 1989), mRNA is expressed in all tissues and is 
approximately 1.5 kb long, encoding a protein of 
390 amino acids (Dahl et al., 1987; De Meirleir et 
al., 1988; Koike et al., 1988; Ho et ah, 1989).
The diagnosis of PDH complex deficiency is 
based primarily on the measurement of lowered 
enzyme complex activity in tissues of the patients. 
Cultured skin fibroblasts are most frequently used 
for diagnosis. As previously mentioned, most of 
the mutations in PDH complex deficiencies are 
found in the Eja-subunit of the complex; however,
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t a b l e  i. Oligonucleotides Used for PCR Amplification
Pair Name Oligonucleotide Length (bp) Position®
A PDS1 5 ' -TGTG AG GAGTCGCCGCTG CC-3 ' 317 69-88
PDS2 5'-CACAAGTGACAGAAACCACG-3' 386-367
B PDS 7 5'-AGACTGTACGCCGAATGGAG-3' 335 311-330
PDS 8 5'-AGGCTAGAGCAATCCCAGCG-3' 646—627
C PDH34 5 ' - AG A ACTTCTACG G G GG C AATGG -3 ' 307 578-599
PDH31 5f - AG G ATATCC ATTCC ATCC AC-3 ' 884-865
D PDH30 5'-TGGCGATGGTGCTGCTAACC-3' 281 687—706
PDH32 5 ' -G GT A AGTCTG C AG CTCC ATC-37 967-948
E PDS3 5'-AGTGGATGGAATGGATATCC-3' 248 864-883
PDS4 5 ' -TTTAGTTCTTCCAC ACTG GC-3 ' 1,112-1,093
F PDS5 5 ' -TA AG AGTG ACCCTATTATG C-3 ' 280 1,041-1,060
PDS6 5'-GTCTGGTAGCCCCCTGAAGG-3' 1,321-1,302
"Positions refer to the numbering of the PDH cDNA sequence in Dahl et al. (1992).
the expression of this gene at the mRNA level does 
not appear to be altered in most of the patients
(Dahl et al., 1992a,b; Dahl and Brown, 1994; De 
Meirleir et al., 1992, 1993, 1994; Chun et al., 
1993; Wexler et al., 1992; Matthews et al., 1993; 
Hansen et al., 1993; Takakubo et al., 1993a,b; 
Endo et al., 1989, 1991). We describe the detec­
tion of mutations in the E|CX gene of eight patients 
with a PDH complex deficiency. Mutation detec­
tion was based on reverse transcription-polymerase 
chain reaction (RT-PCR) of the whole coding re­
gion of the Eta  gene, starting from mRNA isolated 
from fibroblasts, followed by single-strand confor­
mation polymorphism (SSCP) analysis (Orita et 
al., 1989) and direct sequencing of aberrant SSCP 
fragments.
MATERIALS AND METHODS
RNA Preparation and Reverse Transcription
Fibroblasts of the patients were grown in Opti­
mum I medium (Gihco, Ghent, Belgium), supple­
mented with 5% fetal calf serum (FCS), 2 mM 
glutamine, and 50 IU/ml penicillin/streptomycin.
pmol of each primer, 50 mM KCl, 10 mM Tris- 
HCl pH 8*3, 2 mM MgCl2) 2 units of Taq poly­
merase (Perkin-Elmer Cetus, Norwalk, CT), 10
j^lC i of 35S-dATP and 35S-dCTP (1,000 Ci/mmoi; 
Amersham, England) and 0,01% gelatin. The ad­
dition of nonradioactive nucleotides is unnecessary 
due to carryover from the first-strand cDNA mix­
ture. Thermal cycling conditions were dénatur­
ation at 94°C for 30 sec, annealing at 55°C for 30 
sec, and extension at 72°C for 45 sec, for 30 cycles, 
and a final extension at 72°C for 7 min. For SSCP 
analysis, 2.5 |xl of each PCR product was mixed 
with 10 ¡uul of a solution containing 0.1% sodium
dodecyl sulfate (SDS) and 10 mM EDTA, pH 8.0, 
and 10 |xl of 95% formamide, 0,05% bromophenol 
blue, 0,05% xylene cyanol FF, and 20 mM EDTA, 
pH 8,0. Five fxl was removed for the identification 
of double-stranded fragments; the remainder was
heated to 85°C for 5 min and then immediately
placed on ice. Three \xl of nondenatured and de­
natured samples was then loaded on either 6% or 
8% polyacrylamide SSCP gels (acrylamide-to- 
bisacrylamide ratio 29:1 and 37.5:1) with or with-
Total RNA was prepared from one or two 250-ml out 5% glycerol. The different conditions of elec
tissue culture flasks (Gibco) according to the
method of Chomczynski and Sacchi (1987). Five 
|xg of coral RNA was used for first-strand cDNA 
synthesis (Frist-strand cDNA synthesis kit, Phar­
macia, Roosendaal, the Netherlands), according 
to the manufacturer’s instructions in a total vol­
ume of ) Î (jlI.
PCR and SSCP Analysis of the PDH Exo¿ Gene
trophoresis described by Michaud et al. (1992) 
were used. After electrophoresis, the gels were 
fixed in 10% of acetic acid/10% of methanol and 
dried on filter paper. Autoradiography was per­
formed for 24-48 hr.
DNA Sequencing of PDH Eta  cDNA Fragments
After reverse transcription, the 6 PDH Ejcx 
cDNA fragments were PCR amplified in a total
The whole coding sequence of the PDH EjO. volume of 100 |xl. The reaction conditions were
gene was PCR amplified in six consecutive over essentially the same as described above for SSCP
lapping fragments (Table 1, fragments A-F). All analysis, except that 200 |xM each of dNTP and 
reactions were performed in a final volume of 50 jjlI 100 pmol of each primer was added. Radioactive 
containing 5 |xl of first-strand cDNA mixture, 10 nucleotides were omitted from the PCR mixtures,
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TABLE 2, Summary of PDH EjOt Mutations
Patient Sex
1 M
2 F
3 F
4 F
5 M
6 M
7 F
8 M
PDH complex
activity6 (%)
30 
10 
12 
40
31 
15 
29 
15
SSCP fragment
A 
E 
B 
B
D/E 
F 
F
E/F
Nucleotide 
change
C—»T at 319 
C-*T at 1008 
C-»G at 442 
G-»A at 589 
C~»G at 892 
l,264ins39c 
l,217insl3d 
l,069insl5c
Exon
3 
10
4
5 
8
11
10
Amino acid 
change
R72C
R302C
H113D
G162R
R263G
K387fs
S371fs
D322fs
°Sex: M, male; F, female.
b Activities (in fibroblasts) are expressed as percentage of control mean. Mean 1.62 nmol/mg/mm; range l .z l
mg/min (De Meirleir et al., 1992). 
cDirect repeat of bases 1,226-1,264 after 1,264, 
dBases 1,204-1,216 after 1,217. 
eBases 1,055-1,069 after 1,069.
•2.81 nmol/
and an extension time of 1 min was used. After 
amplification, the PCR products were purified on a 
Centricon 100 microconcentrator (Amicon, Bev­
erly, MA, USA) and sequenced in both directions 
by dideoxynucleotide chain termination with the 
PCR primers, using Sequenase Version 2.0 kit (US 
Biochemical Corp., Beverly, MA, USA),
Patients
All patients studied had PDH complex activity 
in fibroblasts, 10-50% of the mean of our control 
values (Table 2), Patient 1 is a boy of nonconsan- 
guinous parents. His initial development was nor­
mal. At the age of 2.5 years, during an intercurrent 
infection, he became severely ataxic and hypo­
tonic, but he recovered within a few days. At the 
age of 3 years, he presented with easy fatiguability 
and difficulties in climbing the stairs. This was 
followed by episodes of dystonia of the lower limbs. 
Ataxia and weakness increased progressively, pre­
venting independent walking. Metabolic workup 
revealed an increased blood lactate and pyruvate, 
with normal lactate/pyruvate ratio. A sensorimotor 
neuropathy was found. Magnetic resonance imag­
ing (MRI) of the brain showed hypodensities in 
basal ganglia. PDH activity in fibroblasts was 30% 
of normal. His condition continues to progress.
The clinical picture of patient 2 was very similar 
to that of a patient described previously (De Meir­
leir et al., 1993). She presented with a severe de­
velopmental delay since birth, Myoclinic seizures 
started at the age of 4 months. She also had agen­
esis of the corpus callosum, as well as cortical at­
rophy and microcephaly. PDH activity measured 
in fibroblasts was 10% of normal.
In patient 3, a developmental delay with hypo­
tonia was noted at the age of seven months. She 
developed spastic diplegia and microcephaly. At
the age of seven years, she was severely retarded. 
PDH activity in fibroblasts was 12% of normal.
Patient 4 also presented with developmental de­
lay and microcephaly. Spastic quadriplegia devel­
oped, and she became severely retarded. Com­
puted tomography (CT) scan of the brain 
demonstrated severe cortical atrophy, and ventric­
ular dilation was seen, PDH activity in fibroblasts 
was 40% of normal.
Patient 5 is a boy who was admitted at the age 
of 16 months with an episode of somnolence, hy­
perventilation and choreic movements. Four ma­
ternal brothers died in the neonatal period of un­
known cause. Blood lactate and pyruvate were 
elevated. MRI of the brain showed hyperintensi­
ties in the caudal and lenticular nucleus, A  diag­
nosis of Leigh’s encephalomyelopathy was pro­
posed. PDH activity in fibroblasts was 31% of 
normal.
Patient 6 is a boy presenting with severe lactic 
acidosis. He died at the age of 18 months. No 
further clinical details are available, PDH activity 
in his fibroblasts was 15% of normal.
Patient 7 has been previously described (Sengers 
et aL, 1983). Patient 8 is a boy presenting with
early onset lactic acidosis, hyperventilation, devel­
opmental delay, and failure to thrive. He died at 
the age of 15 months. PDH activity in fibroblasts 
was 15% of normal.
RESULTS
To permit rapid screening for mutations in the 
PDH Eta  gene, we have designed 12 oligonucle­
otide primers that permit amplification by PCR of 
the whole coding sequence of the gene in six con­
secutive overlapping fragments (Table 1), After 
reverse transcription of total RNA, isolated from 
fibroblasts from eight patients and PCR amplifica-
»
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tion of the six fragments starting from the resulting fragments were systematically less intense than the
cDNAs, the fragments were subjected to SSCP 
analysis. For all eight patients, abnormal migrating 
bands were found, as compared to normal control 
samples (data not shown). The abnormal SSCP 
fragments were A for patient 1, B for patients 3
and 4, D and E for patient 5, E for patient 2, E and 
F for patient 8, and F for patients 6 and 7 (Table 
2). In addition, normal migrating SSCP fragments 
were also detected in all female patients (patients 
2, 3, 4, and 7), indicating that these females were 
heterozygotes carrying one normal and one mu- 
tated Ejtx gene.
The corresponding fragments were re-amplified 
from cDNA f rom each of these eight patients and 
sequenced in both directions. In each case, a mu­
tation was found (Table 2), The sequencing results 
for patients 4, 6, 7» and 8 were reviewed by the 
editors, but are not shown. The heterozygote status 
of all female patients was confirmed. The presence 
of these mutations was confirmed in genomic fi­
broblast ON A of each patient. As expected, for 
the two patients showing two abnormal SSCP frag­
ments (patients 5 and 8), the mutation was found 
in the overlap region of the SSCP fragments.
DISCUSSION
Deficiency of the PDH complex is mostly due to 
defects in the component of the enzyme (Rob­
inson, 199}), So far, no mutations have been 
found in the (3-subunit of E[ (Chun et al,, 1993),
but about 30 mutations have been identified in the 
oKsuhunit. We have developed a rapid screening 
method for the detection of mutations in the EjOt 
gene in patients with a PDH complex deficiency. 
It is based on RT-PCR, followed by SSCP analysis 
and direct sequencing (if aberrant SSCP fragments. 
We have used this screening method for the anal­
ysis of the Eju gene in eight patients; aberrant 
SSCP fragments were found for each patient. Di­
rect sequencing of the corresponding fragments re­
vealed missense mutations in five patients and di­
rect repeat insertions leading to a shift in the 
amino acid reading frame of the E(a  gene in the 
three other patients. The presence of the muta­
tions was confirmed in genomic DNA of all pa­
tients. The four female patients analyzed in this 
study were, as expected, carriers of both a normal 
and a mutated Bjtt gene. They predominantly ex­
press the mutated gene through nonrandom X-in­
activation of the X'chromosome containing the 
normal \ i {a  gene. This is supported by the low 
residual PDH complex activity (Table 1) and is 
also see it in SS( IP analysis where the normal SSCP
aberrant (mutant) fragments.
The five missense mutations are located in ex­
ons 3 (R72C), 4 (H113D), 5 (G162R), 8 
(R263G), and 10 (R302C) and all involve a con­
siderable change in the charge of the predicted 
amino acid substitution. Four of these mutations
are in a CpG dinucleotide (R72C, G162R, 
R263G, and R302C), and three of them (R72C, 
G162R and R302C) could be explained by spon­
taneous deamination of 5-methylcytosine (Cooper 
and Krawczak, 1993). The amino acids at positions 
72, 113, 162, 263, and 302 of the human E ja  gene
are all conserved in the somatic Eza  genes of rat, 
mouse, and pig (Matuda et al., 1991; Fitzgerald et 
al., 1992; Sermon et al., 1990) and in the testis-
specific Etot genes of human and mouse (Dahl et
al., 1990; Fitzgerald et al., 1992). With the ex­
ception of the mother of patient 5, these mutations 
were also absent in the genomic DNA from leuco­
cytes of the parents of the patients. Therefore, we 
believe that these mutations are disease causing. In 
patients 6, 7, and 8, the insertions introduce a 
shift in the amino acid reading frame. The direct 
repeat insertions in these patients predict trun­
cated proteins starting from codons 387, 372, and 
322, respectively, that are 13, 32, and 5 amino 
acids longer than native E{a . The mutation in 
patient 8 was not present in genomic leukocyte 
DNA of his mother, indicating that the mutation 
either occurred de novo or is present in the germ- 
line of the mother. The parents of the two other 
patients were not available for study.
Two of the eight mutations found in our pa­
tients (R263G and R302C) have already been de­
scribed previously (Wexler et al., 1992; Chun et 
al., 1993; Dahl et a l., 1992b; De Meirleir et al., 
1993). The clinical history of female patient 2 
(R302C mutation) is very similar to already de­
scribed patients carrying this mutation. This is also 
true for patient 7 with a 13-bp repeat insertion in 
exon 11 (Sengers et al., 1983). These girls pre­
sented with symptoms in the neonatal period and 
have severe developmental delay, dysmorphism, 
bouts of lactic acidosis, seizures and microcephaly 
with dilated ventricles. By contrast, in female pa­
tients 3 and 4, who have mutations in exons 4 and 
5, the clinical onset is delayed until a few months 
after birth. They do not have severe cortical atro­
phy or developmental brain anomalies as in the 
two other females, but the clinical picture again 
results in a severe mental retardation with micro­
cephaly and spastic quadriplegia.
The mutation R263G has previously been asso­
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ciated with Leigh’s encephalomyelopathy. The 
clinical picture of patient 5 is in accordance with 
this. The patient carrying the R72C mutation, pa­
tient 1, also fits this picture with episodic ataxia 
associated with muscle weakness as an initial symp- 
tom and progressing into a Leigh’s encephalomy- 
elopathy. The clinical normal mother of patient 5 
is a carrier of a normal and a mutated R263G Eta  
gene. In general, mutations in E:a  are not present 
in the parents, suggesting that most PDH muta­
tions represent new mutations (Dahl et al.,
1992a). The R263G mutation, as well as the 
R302C mutation, seem to be exceptions. Re- 
cently, familial transmission of a mutation leading 
to partial skipping of exon 6 of the ELa  gene has
also been demonstrated (De Meirleir et aL, 1994).
Nonrandom X-inactivation resulting in dispropor- 
tional expression favoring the normal or the mu^ 
tated allele could then explain either the normal or 
the affected phenotype in females carrying one of 
these mutations. Obviously males carrying the 
mutated allele would be affected. It has been sug­
gested that the R263G mutation disrupts the sub- 
unit-subunit interaction of the Eta- and E^-sub- 
units resulting in the instability of Ex. The mother 
of our patient had four brothers who died in the 
neonatal period of an unknown cause. Although it 
has not been possible to study these maternal 
brothers, the familial history is compatible with a
R263G PDH Eta  deficiency. The two other boys
have mutations in exons 11 and 10 (patients 6 and 
8); both presented with a severe neonatal lactic 
acidosis and early death*
Several methods have been described for the 
rapid detection of minor changes in nucleic acids 
(for review, see Grompe, 1993). We have chosen 
to use SSCP analysis for the detection of mutations 
in the PDH gene because of its simplicity and 
sensitivity (Hayashi and Yandell, 1993). All the
mutations described in this study were detected in 
SSCP by using 8% polyacrylamide gels (aery la- 
mide-to-bisacrylamide ratio 37.5:1) containing 5% 
glycerol, at room temperature. Moreover, the pat­
terns obtained from normal control samples were 
fully reproducible from experiment to experiment. 
Therefore, we always run the first SSCP under 
these conditions and only, when no aberrant mi­
grating bands are found in patients, other SSCP 
conditions are used (Michaud et al., 1992). The 
possibility of splicing out of an exon from the gene 
was also largely taken into account by designing 
the SSCP primers. Splicing out of all exons, ex­
cept exons 3 and 10, would immediately be obvi­
ous from the SSCP patterns. For mutations result­
ing in splicing out of exons 3 and 10, additional 
amplifications with primers PDS1/PDS8 and 
PDS3/PDS6 would be necessary.
The study of X-inactivation patterns, by anal­
ysing the methylation status of the hypervariable 
DXS255 locus, has been suggested as an aid in the 
diagnosis in females with a suspected PDH E:a  
deficiency (Brown and Brown, 1993). However, 
the methylation status at this locus may be affected 
by factors other than X-chromosome inactivation
(Hendriks etal., 1991; Cachia et a l., 1992). More­
over, skewed X-inactivation will only give an in­
direct indication of a possible involvement of the 
E ^  gene in disease, Since the SSCP system de­
scribed here permits a direct search for mutations 
in the gene, we believe that this system should be 
preferentially used for mutation detection.
In summary, we have developed a RT-PCR- 
based SSCP assay for the detection of mutations in 
the PDH E ja gene. Starting from total RNA, the 
result of the screening can be obtained in 72 hr. 
We have used this method in eight patients with a 
PDH complex deficiency and have found muta­
tions in the ELa  genes of all patients.
*
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